NCT01823133

Study for Investigate the Pharmacokinetic Drug Interactions Between Gemigliptin and Rosuvastatin

A Randomized, Open Label Crossover Study to Investigate the Pharmacokinetic Drug Interactions Between Gemigliptin and Rosuvastatin in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: LG Life Sciences · Industry
• Sex: Male
• Age: 20 Years – 45 Years
• Healthy volunteers: Accepted

Summary

Investigate the pharmacokinetic drug interactions between gemigliptin and rosuvastatin in healthy subjects

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	gemigliptin only	gemigliptin 50mg qd on day 1\~7
DRUG	rosuvastatin only	rosuvastatin 20mg qd on day 1\~7
DRUG	gemigliptin and rosuvastatin	gemigliptin 50mg, rosuvastatin 20mg qd on day 1\~7

Timeline

• Start date: 2013-04-01
• Primary completion: 2013-05-01
• Completion: 2013-08-01
• First posted: 2013-04-04
• Last updated: 2013-08-28

Locations

1 site across 1 country: South Korea